Adil Aboumajd

Adil Aboumajd serves as the Chief Financial Officer for the Central Europe Cluster at AstraZeneca, overseeing financial operations in the Czech Republic, Hungary, and Slovakia since March 2016. Prior to this role, Adil held various positions at AstraZeneca, including Finance Business Partner for Respiratory Immunology Vaccines and Financial Controller for France, where responsibilities ranged from financial transformation and risk management to commercial performance and investment decisions. Previously, Adil worked at Mazars from September 2007 to February 2016, providing financial audit and advisory services to a range of French companies. Adil's academic background includes studies at SKEMA Business School and ISCAE, culminating in a focus on finance and an ongoing commitment to professional development as an Expert-comptable mémorialiste.